Image pharmaphorum Editor Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows. Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future. R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics. Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail. Load more results
Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.
Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.